A Cohort Study of Uterine Malignancies
Launched by WOMEN'S HOSPITAL SCHOOL OF MEDICINE ZHEJIANG UNIVERSITY · Nov 22, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying cervical and endometrial cancers to better understand how factors like age, lifestyle, pregnancy history, and overall health affect these diseases. The researchers want to find out what influences the outcomes for women diagnosed with these types of cancer. They will also analyze biological samples to look for markers that can help diagnose and predict how well patients will do in the future.
To participate in this study, women aged 20 to 75 who have recently been diagnosed with cervical or endometrial cancer are eligible. Participants must be able to understand the study and provide their consent. Those who have other types of cancer, have previously had certain surgeries, or have mental health issues that would prevent them from participating are not eligible. If you join the study, you can expect to provide information about your health and lifestyle, and you may undergo tests to help researchers learn more about these cancers.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 20-75 years;
- • Women with cervical cancer or endometrial cancer with a definite pathological diagnosis for the first time;
- • Women attending a health check-up;
- • Obtain informed consent and sign an informed consent form.
- Exclusion Criteria:
- • Patients who are unable to cooperate with the investigations such as mental disorders or cognitive impairment;
- • Patients with cancer other than cervical cancer or endometrial cancer;
- • Women who have received hysterectomy or pelvic radiation therapy previously.
About Women's Hospital School Of Medicine Zhejiang University
The Women’s Hospital School of Medicine at Zhejiang University is a leading academic institution dedicated to advancing women's health through innovative research and clinical excellence. With a strong focus on obstetrics, gynecology, and reproductive health, the institution conducts cutting-edge clinical trials aimed at improving patient outcomes and enhancing the understanding of women's health issues. Committed to fostering collaboration between researchers, healthcare professionals, and patients, the Women's Hospital School of Medicine plays a pivotal role in translating scientific discoveries into effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hangzhou, Zhejiang, China
Patients applied
Trial Officials
Hui Wang, PhD
Principal Investigator
Women's Hospital School Of Medicine Zhejiang University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials